ArticleCancer immunology, immunotherapy : CII2024

CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors.

Jianghua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.